Chen, K., Liu, M. X., Mak, C. S., Yung, M. M., Leung, T. H., Xu, D., . . . Chan, D. W. (2018). Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways. Theranostics.
Chicago ZitierstilChen, Kangmei, et al. "Methylation-associated Silencing of MiR-193a-3p Promotes Ovarian Cancer Aggressiveness By Targeting GRB7 and MAPK/ERK Pathways." Theranostics 2018.
MLA ZitierstilChen, Kangmei, et al. "Methylation-associated Silencing of MiR-193a-3p Promotes Ovarian Cancer Aggressiveness By Targeting GRB7 and MAPK/ERK Pathways." Theranostics 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.